[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BBV152A; BBV152B and BBV152C: Whole-Virion Inactivated SARS-CoV-2 vaccine (BBV152) with three formulations; BBV152A; BBV152B and BBV152C. Dose: 0.5ml; Route of administration:Intramuscular injection; Frequency: Two doses at Day 0 and Day 14Control Intervention1: JENVAC\u00c2\u00ae: JE vaccine (JENVAC\u00c2\u00ae) will be used as a control. Dose:0.5ml Route of administration:Intramuscular injection; Frequency:Two dose at day 0 and day 14Control Intervention2: Placebo: Placebo will be used as a control. Dose: 0.5ml Route of administration:Intramuscular injection; Frequency:Two doses at Day 0 and Day 14", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BBV152A; BBV152B and BBV152C: Whole-Virion Inactivated SARS-CoV-2 vaccine (BBV152) with three formulations; BBV152A; BBV152B and BBV152C. Dose: 0.5ml; Route of administration:Intramuscular injection; Frequency: Two doses at Day 0 and Day 14Control Intervention1: JENVAC\u00c2\u00ae: JE vaccine (JENVAC\u00c2\u00ae) will be used as a control. Dose:0.5ml Route of administration:Intramuscular injection; Frequency:Two dose at day 0 and day 14Control", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: JENVAC\u00c2\u00ae: JE vaccine (JENVAC\u00c2\u00ae) will be used as a control. Dose:0.5ml Route of administration:Intramuscular injection; Frequency:Two dose at day 0 and day 14Control Intervention2: Placebo: Placebo will be used as a control. Dose: 0.5ml Route of administration:Intramuscular injection; Frequency:Two doses at Day 0 and Day 14", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "0,5ml;2;day0-14;IM", "treatment_id": 1387, "treatment_name": "Covaxin", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BBV152A; BBV152B and BBV152C: Whole-Virion Inactivated SARS-CoV-2 vaccine (BBV152) with three formulations; BBV152A; BBV152B and BBV152C. Dose: 0.5ml; Route of administration:Intramuscular injection; Frequency: Two doses at Day 0 and Day 14Control Intervention1: JENVAC\u00c2\u00ae: JE vaccine (JENVAC\u00c2\u00ae) will be used as a control. Dose:0.5ml Route of administration:Intramuscular injection; Frequency:Two dose at day 0 and day 14Control Intervention2: Placebo: Placebo will be used as a control. Dose: 0.5ml Route of administration:Intramuscular injection; Frequency:Two doses at Day 0 and Day 14", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BBV152A; BBV152B and BBV152C: Whole-Virion Inactivated SARS-CoV-2 vaccine (BBV152) with three formulations; BBV152A; BBV152B and BBV152C. Dose: 0.5ml; Route of administration:Intramuscular injection; Frequency: Two doses at Day 0 and Day 14Control Intervention1: JENVAC\u00c2\u00ae: JE vaccine (JENVAC\u00c2\u00ae) will be used as a control. Dose:0.5ml Route of administration:Intramuscular injection; Frequency:Two dose at day 0 and day 14Control", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: JENVAC\u00c2\u00ae: JE vaccine (JENVAC\u00c2\u00ae) will be used as a control. Dose:0.5ml Route of administration:Intramuscular injection; Frequency:Two dose at day 0 and day 14Control Intervention2: Placebo: Placebo will be used as a control. Dose: 0.5ml Route of administration:Intramuscular injection; Frequency:Two doses at Day 0 and Day 14", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]